Genome Engineering Market is Estimated to Witness High Growth Owing to Increasing Applications of Synthetic Biology

Comments ยท 2 Views

Genome engineering involves modifying the genome of an organism in order to modify or regulate gene expression and functions. Genome engineering tools such as zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and CRISPR-Cas9 system are used for applications like gene therapy, disease modeling, biological research and cellular reprogramming. These tools are used for developing therapies for genetic disorders as well as enhancing agricultural crops and developing biologics.

The global genome engineering market is estimated to be valued at US$ 6.87 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

One of the key driver responsible for the high growth of genome engineering market is increasing applications of synthetic biology. Synthetic biology leverages genome engineering tools and techniques to design and construct new biological parts, devices and systems as well as redesign existing natural biological systems. Genome engineering tools play a critical role in advancing capabilities of synthetic biology for a wide range of applications such as developing genetically engineered organisms for production of biofuels, drugs, chemicals and materials. Rising investments in synthetic biology is expected to significantly drive the demand for genome engineering tools over the forecast period. Moreover, increasing efforts towards drug discovery and development of advanced therapeutics such as immuno-oncology drugs, gene therapies and cell therapies will further contribute to the growth of genome engineering market during the forecast period.

SWOT Analysis
Strength: Genome engineering tools have gained significant adoption in recent years, especially in biotechnology and pharmaceutical industries. The technology allows precise and targeted alteration of genomes, driving innovation. Genome sequencing and editing are becoming more affordable and accessible, allowing for broader applications.

Weakness: Ethical and safety concerns surround the technology regarding human gene editing and genetic modifications. Regulations vary globally creating challenges. Potential off-target effects and unintended DNA mutations require careful validation of genome editing tools. High infrastructure investments and expertise are needed for advanced research.

Opportunity: The technology enables major advancements in treating genetic diseases, developing new therapeutic modalities like gene/cell therapies. Growing R&D in disease modeling, drug development and agriculture/food sectors present opportunities. Emerging CRISPR applications beyond research tools indicate commercial potential. Developing countries expanding genomics initiatives will drive future demand.

Threats: Intellectual property disputes between key players may impact innovation. Strict regulations in some regions limit applications and commercial use of engineered organisms. Societal resistance to human genome editing. Alternate gene editing/modulation techniques may disrupt the market in future.

Key Takeaways
Global Genome Engineering Market Size is expected to witness high growth over the forecast period of 2024 to 2031.

Regional analysis: North America currently dominates the global market due to heavy investments in genomic research and regulatory support for applications. However, Asia Pacific is anticipated to grow at the fastest pace during the forecast period on back of initiatives in India and China aimed at genomic applications to address health and agriculture issues.

Key players: Key players operating in the Genome Engineering market include Accenture, Appian Corporation, Genpact, Infosys Limited (Infosys BPM), Open Text Corporation, Kissflow Inc., Nintex Global Ltd., Software AG, International Business Machines Corporation, Tata Consultancy Services Limited., and Pegasystems Inc. These companies are focusing on developing innovative genome editing tools and technologies to enable advanced applications. Partnerships with research institutes are helping expand clinical research applications.

Get More Insights on This Topic- https://www.dailyprbulletin.com/genome-engineering-market-value-insights-and-outlook/

Explore More Related Trending Articles- https://lotstoexpress.com/whispers-of-the-genomics-exploring-the-secrets-hidden-in-every-stand/

disclaimer
Read more
Comments